Clinical Trial Update: Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing 1 versus 10 intradetrusor injections of botulinum toxin A for overactive bladder, evaluating efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Urge Incontinence

Drugs mentioned

• Botulinum toxin A (onabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: University of California, Irvine | Conditions: Overactive Bladder, Urinary Urge Incontinence | Phase 4 | Status: COMPLETED | Results posted: 2025-02-14